VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,104,732 | +162.1% | 255,725 | +348.3% | 0.00% | +50.0% |
| Q4 2022 | $421,540 | -33.1% | 57,042 | -1.4% | 0.00% | -60.0% |
| Q2 2022 | $630,000 | -36.7% | 57,842 | -34.3% | 0.01% | -37.5% |
| Q1 2022 | $996,000 | -21.4% | 88,076 | +9.0% | 0.01% | -20.0% |
| Q4 2021 | $1,267,000 | +29.8% | 80,779 | +24.3% | 0.01% | -33.3% |
| Q1 2021 | $976,000 | +356.1% | 64,980 | +298.1% | 0.02% | +400.0% |
| Q4 2020 | $214,000 | +41.7% | 16,324 | +4.3% | 0.00% | +50.0% |
| Q3 2020 | $151,000 | -23.7% | 15,654 | +30.1% | 0.00% | -66.7% |
| Q4 2019 | $198,000 | – | 12,036 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |